Literature DB >> 6174836

Interferon system in acute viral hepatitis.

S Levin, T Hahn.   

Abstract

Activation of the interferon system is an early antiviral immune defence mechanism. In 16 patients, whose viral hepatitis (A, B, and non-A, non-B) ran a normal course, blood interferon levels rose and cells were rapidly induced into an antiviral states. However, in 6 patients with acute fulminant hepatitis, the antiviral interferon system was grossly defective. Blood interferon levels were not measurable in 5 of them; in all 6, the mononuclear cells were not in an antiviral state and did not produce interferon-alpha or interferon-gamma when stimulated, but their intracellular antiviral mechanism was intact because small amounts of exogenous interferon induced an antiviral state in vitro. 5 of the patients with fulminant hepatitis received interferon-alpha therapy, with rapid activation of their interferon systems, accompanied by rapid and uncomplicated recoveries in 3. It is suggested that interferon be given a trial as an early treatment for severe viral hepatitis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174836     DOI: 10.1016/s0140-6736(82)91751-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

Review 1.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

2.  Natural killer activity in patients with acute viral hepatitis.

Authors:  L Chemello; M Mondelli; F Bortolotti; E Schiavon; P Pontisso; A Alberti; E G Rondanelli; G Realdi
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

3.  HBsAg-induced interferon-gamma secretion in T cells from asymptomatic HBsAg carriers and HB-immune donors in vitro.

Authors:  S P Sylvan; U B Hellström
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

4.  Interferon deficiency syndrome.

Authors:  S Levin; T Hahn
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

5.  Interferon in acute viral infections.

Authors:  S Levin
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

6.  A novel role for IFN-stimulated gene factor 3II in IFN-γ signaling and induction of antiviral activity in human cells.

Authors:  Angel N Morrow; Hana Schmeisser; Takaya Tsuno; Kathryn C Zoon
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

7.  Immunolocalization of alpha interferon in liver disease.

Authors:  C G Sutherland; A M al-Badri; A G Howatson; M A Farquharson; A K Foulis
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

8.  Interferon alpha and gamma positive mononuclear cells and HLA antigen expression on hepatocyte membrane in the liver in chronic type B and non-A, non-B hepatitis.

Authors:  M Arao; S Kakumu; H Tahara; K Yoshioka; N Sakamoto
Journal:  Gastroenterol Jpn       Date:  1989-06

9.  Attempted treatment of fulminant viral hepatitis with human fibroblast interferon.

Authors:  F Milazzo; M Galli; P G Fassio; A Cargnel; A Pugliese; P A Tovo; G M Vigevani; R Esposito; A Lazzarin; F Caredda
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

10.  Naturally occurring anti-interferon-alpha 2a antibodies in patients with acute viral hepatitis.

Authors:  Y Ikeda; G Toda; N Hashimoto; N Umeda; K Miyake; M Yamanaka; K Kurokowa
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.